The SAKIGAKE Designation Expansion: Fast-Tracking Breakthrough Innovation in Japan
This post details the strategic expansion of the SAKIGAKE system in 2026, a regulatory accelerator that redefines the market entry timeline for cutting-edge therapies and orphan drugs in Japan.